Profile data is unavailable for this security.
About the company
Jiangsu gdk Biotechnology Co Ltd is a biopharmaceutical company engaged in the research, development, production, and sales of human vaccines. The Company’s main product is a tetravalent influenza virus split vaccine, which is mainly used to prevent influenza caused by two influenza A virus strains and two influenza B virus strains. The Company's research products also include a variety of human vaccines for the prevention of epidemic colds, rabies, chickenpox, shingles, and pneumonia. The Company distributes its service within the domestic market.
- Revenue in CNY (TTM)33.39m
- Net income in CNY-128.83m
- Incorporated2008
- Employees451.00
- LocationJiangsu GDK Biotechnology Co LtdNo. 12 Yujin RoadTAIZHOU 225300ChinaCHN
- Phone+86 52 386205860
- Fax+86 52 386200152
- Websitehttp://www.gdkbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Shengda Bio-pharm Co Ltd | 742.96m | -53.74m | 2.10bn | 1.03k | -- | 1.68 | -- | 2.82 | -0.3325 | -0.3325 | 4.27 | 7.31 | 0.4409 | 2.33 | 6.08 | 719,919.20 | -3.10 | 3.39 | -3.71 | 4.42 | 15.03 | 28.58 | -7.02 | 7.57 | 1.41 | -- | 0.2268 | 39.98 | -1.44 | 8.10 | -271.70 | -- | 11.22 | -6.89 |
| Jiangsu gdk Biotechnology Co Ltd | 33.39m | -128.83m | 2.18bn | 451.00 | -- | 1.62 | -- | 65.42 | -1.04 | -1.04 | 0.2686 | 10.95 | 0.0193 | 0.4185 | 0.1529 | 74,034.57 | -7.45 | 3.30 | -8.73 | 4.84 | 51.14 | 75.56 | -385.83 | 12.58 | 3.20 | -- | 0.048 | 32.60 | -57.74 | -- | -270.88 | -- | 54.07 | -- |
| Jiangsu Cowin Biotech Co Ltd | 123.20m | -117.37m | 2.18bn | 657.00 | -- | 1.34 | -- | 17.73 | -1.12 | -1.12 | 1.21 | 14.49 | 0.0664 | 1.33 | 1.23 | 187,520.90 | -6.63 | -- | -6.94 | -- | 58.15 | -- | -99.82 | -- | 14.37 | -- | 0.0184 | -- | -67.15 | -- | -153.00 | -- | -- | -- |
| Hanshang Group Co Ltd | 1.36bn | 49.62m | 2.23bn | 2.38k | 44.35 | 1.30 | -- | 1.64 | 0.1707 | 0.1707 | 4.65 | 5.84 | 0.3705 | 2.75 | 8.35 | 573,421.20 | 1.16 | 2.00 | 1.92 | 3.89 | 58.35 | 57.24 | 3.13 | 4.89 | 0.3366 | 2.15 | 0.3198 | 15.03 | 0.1893 | 5.14 | -32.24 | 25.62 | 12.88 | -- |
| Shanghai Shen Lian Biomedical Corp | 281.44m | 25.86m | 2.28bn | 365.00 | 88.30 | 1.52 | -- | 8.11 | 0.063 | 0.063 | 0.6854 | 3.66 | 0.1731 | 0.7474 | 0.9025 | 771,056.40 | 1.54 | 6.85 | 1.65 | 7.54 | 70.64 | 79.21 | 8.92 | 29.63 | 6.58 | -- | 0.0008 | 30.78 | -8.32 | 1.70 | -44.56 | -9.14 | -2.08 | -- |
| Xinjiang Bai Hua Cun Pharma Tech Co Ltd | 384.44m | 26.95m | 2.33bn | 787.00 | 86.32 | 3.20 | -- | 6.07 | 0.0708 | 0.0708 | 1.01 | 1.91 | 0.367 | 1.38 | 1.79 | 488,492.20 | 2.57 | -4.59 | 3.60 | -6.24 | 48.38 | 29.54 | 7.01 | -18.40 | 1.44 | -- | 0.0021 | -- | 5.54 | -2.50 | 137.33 | -- | -21.00 | -- |
Data as of May 17 2024. Currency figures normalised to Jiangsu GDK Biotechnology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2023 | 422.50k | 0.99% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 334.66k | 0.78% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2023 | 119.67k | 0.28% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2023 | 88.80k | 0.21% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 75.93k | 0.18% |
| Harvest Fund Management Co., Ltd.as of 30 Jun 2023 | 60.68k | 0.14% |
| Minsheng Royal Fund Management Co., Ltd.as of 30 Jun 2023 | 54.41k | 0.13% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 45.45k | 0.11% |
| E Fund Management Co., Ltd.as of 30 Jun 2023 | 35.51k | 0.08% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 19.72k | 0.05% |
More ▼
Data from 30 Jun 2023 - 29 Apr 2024Source: FactSet Research Systems Inc.
